39
Ablative Therapy for Ventricular Tachycardia Nitish Badhwar, MD, FACC, FHRS 2 nd Annual UC Davis Heart and Vascular Center Cardiovascular Nurse / Technologist Symposium May 5, 2012

Ablative Therapy for Ventricular Tachycardia

  • Upload
    others

  • View
    7

  • Download
    0

Embed Size (px)

Citation preview

Page 1: Ablative Therapy for Ventricular Tachycardia

Ablative Therapy for Ventricular Tachycardia

Nitish Badhwar, MD, FACC, FHRS

2nd Annual UC Davis Heart and Vascular Center Cardiovascular Nurse / Technologist Symposium

May 5, 2012

Page 2: Ablative Therapy for Ventricular Tachycardia

Disclosures

Research grant - St. Jude, Stereotaxis Honoraria - St. Jude, Boston Scientific, Janssen

Page 3: Ablative Therapy for Ventricular Tachycardia

• Non-sustained ventricular tachycardia (NSVT) – 3 or more consecutive QRS complexes of ventricular origin at rate of

more than 100 bpm

• Sustained VT – Lasts more than 30 seconds, usually requires intervention for termination

• Monomorphic VT – Uniform QRS configuration

• Polymorphic VT – Beat to beat variation in QRS configuration

• Electrical storm – > 3 VT/VF episodes in 24 hours

Ventricular Tachycardia

Page 4: Ablative Therapy for Ventricular Tachycardia

1. Catheter Ablation

2. Urgent left heart catheterization

3. Start I/V Amiodarone

4. Do Nothing

What is the best treatment option?

Page 5: Ablative Therapy for Ventricular Tachycardia

Wide Complex Tachycardia: Artifact

Page 6: Ablative Therapy for Ventricular Tachycardia

• Sudden cardiac arrest (ventricular fibrillation)

• Syncope, near syncope

• Palpitations with wide complex tachycardia (hemodynamically tolerated) or frequent PVCs

Ventricular Tachycardia

Presenter
Presentation Notes
SCA death due to unexpected circulatory arrest usually due to cardiac arrhythmias within 1 hour of symptom onset (scd =death, sca=medical intervention reverses arrest. 13% of all natural deaths
Page 7: Ablative Therapy for Ventricular Tachycardia

• Idiopathic VT

• VT associated with structural heart disease

Ventricular Tachycardia

Page 8: Ablative Therapy for Ventricular Tachycardia

Idiopathic Ventricular Tachycardia

• Long QT syndrome • Brugada syndrome • Short coupled

torsades • Short QT syndrome • Catecholamine

induced polymorphic V T

• Idiopathic VF

• Outflow tract VT- RVOT VT, LVOT VT,cusp VT

• Fascicular VT- LAF, LPF, Septal

• Annular VT- Mitral, Tricuspid

• VT from crux of heart

Polymorphic VT /VF Monomorphic VT

Page 9: Ablative Therapy for Ventricular Tachycardia

I II III

aVL

aVF V1 V2 V3

V5 V6

V4

aVR

Right Ventricular Outflow Tract VT

Page 10: Ablative Therapy for Ventricular Tachycardia

Pulmonary valve

Tricuspid valve

Ablation site

Right Ventricular Outflow Tract VT

Page 11: Ablative Therapy for Ventricular Tachycardia

Outflow Tract VT

Page 12: Ablative Therapy for Ventricular Tachycardia

Outflow Tract VT requiring Epicardial Ablation

CS

Epi

Epi

CS

Page 13: Ablative Therapy for Ventricular Tachycardia

Left main coronary artery

Ablation catheter

Outflow Tract VT: Ablation in the Left Aortic Cusp

Page 14: Ablative Therapy for Ventricular Tachycardia

Aortic Cusp VT ECG Criteria • Early transition in precordial leads (V1, V2) • Notch in V5, lack of S in V5, V6 • Broad R wave in V1, V2 • Larger R/S amplitude in V1, V2 • Notch in V1 in L cusp VT (transeptal conduction) • Lead I negative in L cusp, positive in R cusp • Phase analysis (as measured from earliest

surface onset) – Local onset in V2 ≥ 7 ms – Initial peak / nadir in III ≥ 120 ms – Initial peak / nadir in V2 ≥ 78 ms

Page 15: Ablative Therapy for Ventricular Tachycardia

• Induction with atrial pacing • RBBB, LAD • No structural heart disease (Zipes, 1979) • Verapamil sensitive (Belhassen, 1981) • RBBB, RAD (Ohe, 1988) • Upper septal (Shimoike, 2000)

Fascicular VT

Page 16: Ablative Therapy for Ventricular Tachycardia

Left Posterior Fascicular VT

Badhwar N, Scheinman MM. Curr Probl Cardiol. 2007; 32(1): 7-43.

Page 17: Ablative Therapy for Ventricular Tachycardia

Left Posterior Fascicular VT

Page 18: Ablative Therapy for Ventricular Tachycardia

Left Anterior Fascicular PVCs

Page 19: Ablative Therapy for Ventricular Tachycardia

a. Anterolateral

b. Posterior

c. Posteroseptal

Mitral Annular PVCs / VT

Page 20: Ablative Therapy for Ventricular Tachycardia

1. Septal a. Qs in V1

b. Narrower

c. No notching

2. Lateral a. rS in V1

b. Wider

c. Notching

Tricuspid Annular PVCs / VT

Page 21: Ablative Therapy for Ventricular Tachycardia

VT arising from the Crux of the Heart

Page 22: Ablative Therapy for Ventricular Tachycardia

LAO RAO

VT arising from the Crux of the Heart

Presenter
Presentation Notes
These VTs tend to cluster around PDA branch of RCA and one has to avoid damage to artery with ablation.
Page 23: Ablative Therapy for Ventricular Tachycardia

• Idiopathic VT

• VT associated with structural heart disease

Page 24: Ablative Therapy for Ventricular Tachycardia
Page 25: Ablative Therapy for Ventricular Tachycardia

3D mapping of LV showing scar in a patient with ischemic cardiomyopathy

Page 26: Ablative Therapy for Ventricular Tachycardia

Ventricular Tachycardia with Structural Heart Disease

• Coronary artery disease • Idiopathic dilated cardiomyopathy • Hypertrophic cardiomyopathy (HOCM) • Arrhythmogenic right ventricular

cardiomyopathy (ARVC) • Infiltrative cardiomyopathy- amyloidosis,

sarcoidosis • Chagas disease

Presenter
Presentation Notes
70% of amyloidosis involves the heart-----conduction system, restrictive cardiomyopathy and sudden death. Sarcoidosis involves heart in 13-25%. Posterior wall of LV with aneurysm formation
Page 27: Ablative Therapy for Ventricular Tachycardia

Ventricular Tachycardia with Structural Heart Disease

• Congenital heart disease – Tetrology of Fallot, aortic stenosis

• Valvular heart disease – Pre surgery – Post surgical repair

• Mitral valve prolapse – Right sided AV bundle, fibrotic scars in septum, degenerative

changes in conduction system

• Myotonic dystrophy – AV block more common

• Familial VT – Genetic abnormality of conduction system

Presenter
Presentation Notes
70% of amyloidosis involves the heart-----conduction system, restrictive cardiomyopathy and sudden death. Sarcoidosis involves heart in 13-25%. Posterior wall of LV with aneurysm formation
Page 28: Ablative Therapy for Ventricular Tachycardia

Arrhythmogenic Right Ventricular Cardiomyopathy (ARVC)

Page 29: Ablative Therapy for Ventricular Tachycardia

ARVC: VT arising from Right Ventricle

29

Page 30: Ablative Therapy for Ventricular Tachycardia

Role of imaging modalities in the diagnosis of ARVC

Holter

RV angio

Carto

MRI

30

Presenter
Presentation Notes
2 Magnets produce a spherical magnetic field that can be set in 360 degrees Magnets placed in the catheter tips
Page 31: Ablative Therapy for Ventricular Tachycardia

Non ischemic Dilated Cardiomyopathy

• Annular scar • VT arising from the conduction system (bundle

branch reentry, fascicular, interfascicular • Epicardial scar

Page 32: Ablative Therapy for Ventricular Tachycardia

Bundle Branch Reentry VT

Page 33: Ablative Therapy for Ventricular Tachycardia

Catheter Ablation of Right Bundle Branch

I II V1

RA

Current

Voltage

Presenter
Presentation Notes
Notice the abrupt transition from the LBBB to the RBBB during RF. Also note the significant PR prolongation both before and after RF. Severe His/Purkinje delay is required for this tachycardia to occur.
Page 34: Ablative Therapy for Ventricular Tachycardia

Epicardial VT in Patient with Dilated Cardiomyopathy

Page 35: Ablative Therapy for Ventricular Tachycardia

Epicardial VT

• Chagas 30-40% • Non ischemic cardiomyopathy 25-50% • Ischemic cardiomyopathy 10-15% • ARVC 5-10% • LV aneurysm, Sarcoid, Non compaction • Idiopathic VT 10% (mainly around epicardial

arteries)

Presenter
Presentation Notes
Epicardial idiopathic VTs cluster in the region adjacent to the aortic sinus of Valsalva (ASOV), the great cardiac vein, the anterior interventricular vein, the middle cardiac vein, and other areas of the coronary venous system, or around the coronary arteries
Page 36: Ablative Therapy for Ventricular Tachycardia

Epicardial Mapping

Presenter
Presentation Notes
Technique described by Sosa, done in LAO aim towards left shoulder, with special epidural needle contrast injection, anterior vs inferior stick depends on angle of needle (horizontal or vertical), leave pig tail or remove after procedure, role of steroid injection
Page 37: Ablative Therapy for Ventricular Tachycardia

Epicardial VT: EKG criteria

• QRS duration > 200 ms • Pseudo delta wave > 34 ms • Intrinsicoid deflection > 85 ms • Shortest RS > 121 ms • Precordial MDI > 0.55 ms • Non ischemic cardiomyopathy: lack of q

wave in inferior leads, positive q wave in lead I

Page 38: Ablative Therapy for Ventricular Tachycardia

• Ventricular tachycardia is an important cause of sudden cardiac arrest

• ECG characteristics can localize the site and origin of VT

• Idiopathic VT – Monomorphic VT / Frequent PVCs curable with catheter ablation – Polymorphic VT treated with ICD and drugs

• VT associated with structural heart disease

– ICD and antiarrhythmic drugs – Catheter ablation is mainly palliative, improved efficacy with epicardial

mapping, impella/echmo/IABP

Ventricular Tachycardia

Presenter
Presentation Notes
Given these findings this technique has the potential to improve clinical response in patients requiring resynchronization therapy
Page 39: Ablative Therapy for Ventricular Tachycardia

Thank you